English

KIORA PHARMACEUTICALS, INC.

EDGAR

EYEG Current report (8-K) · filed 2026-10-29

Annual consolidated revenue for 2025: about USD 0, using the latest reported figures. The previous period, 2024, was about USD 16.02M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2025 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-2.18 million USD

2025 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -9961176 USD Source
Operating Cash Flow: -7780721 USD Source

Free cash flow

-2.26 million USD

2025 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -9961176 USD Source
Operating Cash Flow: -7780721 USD Source
Capital Expenditure: 110789 USD Source
Capital Expenditure: 32626 USD Source

Cash and cash equivalents: 7.08 million USD 2026-06-30 Source
Exact value

7076533 USD
Long-term debt including current maturities: Not available
Shares outstanding: 4.43 million shares 2026-06-30 Source
Exact value

4427167 shares

Reported share-count change

28.94% · 994 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

3433491 shares · 2025-06-30· Source
4427167 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2025-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-100%

Prior period

USD 16.02 million

2024-01-01 – 2024-12-31
Current period

USD 0

2025-01-01 – 2025-12-31

Exact inputs and evidence

0 − 16020000 = -16020000 USD

16020000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Year-over-year change in Revenue: -16020000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#935109 Filing: 000137251426000024 Input fundies:Revenue: 16020000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#935711 Filing: 000137251426000024
The citation records this snapshot. The page link may show a newer release later.
Net income
-401.4%

Prior period

USD 3.59 million

2024-01-01 – 2024-12-31
Current period

−USD 10.84 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-10835154 − 3594733 = -14429887 USD

3594733 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-10835154 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Year-over-year change in Net income: -14429887 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -10835154 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1094683 Filing: 000137251426000024 Input fundies:NetIncome: 3594733 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1095446 Filing: 000137251426000024
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-216.4%

Prior period

USD 8.56 million

2024-01-01 – 2024-12-31
Current period

−USD 9.96 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-9961176 − 8559115 = -18520291 USD

8559115 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-9961176 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Year-over-year change in Operating cash flow: -18520291 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -9961176 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1126938 Filing: 000137251426000024 Input fundies:OperatingCashFlow: 8559115 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1127585 Filing: 000137251426000024
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+1,670.9%

Prior period

USD 6,256

2024-01-01 – 2024-12-31
Current period

USD 110,789

2025-01-01 – 2025-12-31

Exact inputs and evidence

110789 − 6256 = 104533 USD

6256 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
110789 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Year-over-year change in Capital expenditure: 104533 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 110789 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1129415 Filing: 000137251426000024 Input fundies:CapitalExpenditure: 6256 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1130000 Filing: 000137251426000024
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 0
Operating costs Derived USD 12.83 million
Operating income −USD 12.83 million
Tax, interest and other Derived −USD 2 million
Net income −USD 10.84 million

Cash

Operating cash flow −USD 9.96 million
Capital expenditure USD 110,789
Free cash flow Derived −USD 10.07 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Operating loss: operating costs were 756% of revenue.
2023 Not shown: operating income or net income is not reported.
2024 22%72%
2025 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	0	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2015-01-01 – 2015-12-31: 0 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -4459169 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	669259	Unavailable	Unavailable	Unavailable	Unavailable	-8413180 Derived	Source 2016-01-01 – 2016-12-31: 669259 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -8413180 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	407518	Unavailable	Unavailable	Unavailable	-13217917	-6505540 Derived	Source 2017-01-01 – 2017-12-31: 407518 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -13217917 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -6468541 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 36999 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1652520	12497221 Derived	-10844701	-33278 Derived	-10811423	-10864512 Derived	Source 2018-01-01 – 2018-12-31: 1652520 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -10844701 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -10811423 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -10844512 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 20000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	0	12586896 Derived	-12586896	-73000 Derived	-12513896	-9556951 Derived	Source 2023-01-01 – 2023-12-31: 0 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -12586896 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -12513896 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -9556951 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	16020000	11509712 Derived	4510288	915555 Derived	3594733	8552859 Derived	Source 2024-01-01 – 2024-12-31: 16020000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 4510288 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 3594733 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 8559115 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 6256 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	0	12831073 Derived	-12831073	-1995919 Derived	-10835154	-10071965 Derived	Source 2025-01-01 – 2025-12-31: 0 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -12831073 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -10835154 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -9961176 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 110789 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	0	Revenue: 0 Open source
20162016-12-31	Revenue	669259	Revenue: 669259 Open source
20172017-12-31	Revenue	407518	Revenue: 407518 Open source
20182018-12-31	Revenue	1652520	Revenue: 1652520 Open source
20232023-12-31	Revenue	0	Revenue: 0 Open source
20242024-12-31	Revenue	16020000	Revenue: 16020000 Open source
20252025-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 669259 Open source Revenue: 0 Open source
20172017-12-31	Year over year	-39.1%	Revenue: 407518 Open source Revenue: 669259 Open source
20182018-12-31	Year over year	305.5%	Revenue: 1652520 Open source Revenue: 407518 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20242024-12-31	Year over year	No prior comparable period	Revenue: 16020000 Open source Revenue: 0 Open source
20252025-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 16020000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 28.2% 2024

Net margin 22.4% 2024

Free cash flow margin 53.4% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Operating margin	Not reported	Revenue: 0 Open source
2016-12-31	Operating margin	Not reported	Revenue: 669259 Open source
2017-12-31	Operating margin	Not reported	Revenue: 407518 Open source
20182018-12-31	Operating margin	-656.3%	Operating Income: -10844701 Open source Revenue: 1652520 Open source
20232023-12-31	Operating margin	Not reported	Operating Income: -12586896 Open source Revenue: 0 Open source
20242024-12-31	Operating margin	28.2%	Operating Income: 4510288 Open source Revenue: 16020000 Open source
20252025-12-31	Operating margin	Not reported	Operating Income: -12831073 Open source Revenue: 0 Open source
2015-12-31	Net margin	Not reported	Revenue: 0 Open source
2016-12-31	Net margin	Not reported	Revenue: 669259 Open source
20172017-12-31	Net margin	-3,243.5%	Net Income: -13217917 Open source Revenue: 407518 Open source
20182018-12-31	Net margin	-654.2%	Net Income: -10811423 Open source Revenue: 1652520 Open source
20232023-12-31	Net margin	Not reported	Net Income: -12513896 Open source Revenue: 0 Open source
20242024-12-31	Net margin	22.4%	Net Income: 3594733 Open source Revenue: 16020000 Open source
20252025-12-31	Net margin	Not reported	Net Income: -10835154 Open source Revenue: 0 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -4459169 Open source
20162016-12-31	Free cash flow margin	-1,257.1%	Revenue: 669259 Open source Operating Cash Flow: -8413180 Open source Capital Expenditure: 0 Open source
20172017-12-31	Free cash flow margin	-1,596.4%	Revenue: 407518 Open source Operating Cash Flow: -6468541 Open source Capital Expenditure: 36999 Open source
20182018-12-31	Free cash flow margin	-657.5%	Revenue: 1652520 Open source Operating Cash Flow: -10844512 Open source Capital Expenditure: 20000 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9556951 Open source Capital Expenditure: 0 Open source
20242024-12-31	Free cash flow margin	53.4%	Revenue: 16020000 Open source Operating Cash Flow: 8559115 Open source Capital Expenditure: 6256 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9961176 Open source Capital Expenditure: 110789 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-4459169	Operating Cash Flow: -4459169 Open source
20162016-12-31	Operating cash flow	-8413180	Operating Cash Flow: -8413180 Open source
20172017-12-31	Operating cash flow	-6468541	Operating Cash Flow: -6468541 Open source
20182018-12-31	Operating cash flow	-10844512	Operating Cash Flow: -10844512 Open source
20232023-12-31	Operating cash flow	-9556951	Operating Cash Flow: -9556951 Open source
20242024-12-31	Operating cash flow	8559115	Operating Cash Flow: 8559115 Open source
20252025-12-31	Operating cash flow	-9961176	Operating Cash Flow: -9961176 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -10.1M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4459169 Open source
20162016-12-31	Free cash flow	-8413180	Operating Cash Flow: -8413180 Open source Capital Expenditure: 0 Open source
20172017-12-31	Free cash flow	-6505540	Operating Cash Flow: -6468541 Open source Capital Expenditure: 36999 Open source
20182018-12-31	Free cash flow	-10864512	Operating Cash Flow: -10844512 Open source Capital Expenditure: 20000 Open source
20232023-12-31	Free cash flow	-9556951	Operating Cash Flow: -9556951 Open source Capital Expenditure: 0 Open source
20242024-12-31	Free cash flow	8552859	Operating Cash Flow: 8559115 Open source Capital Expenditure: 6256 Open source
20252025-12-31	Free cash flow	-10071965	Operating Cash Flow: -9961176 Open source Capital Expenditure: 110789 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

33.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	36%	Total Liabilities: 3420935 Open source Total Assets: 9507701 Open source
20162016-12-31	Liabilities / assets	103.4%	Total Liabilities: 10060023 Open source Total Assets: 9730602 Open source
20172017-12-31	Liabilities / assets	113.5%	Total Liabilities: 16232314 Open source Total Assets: 14305392 Open source
20182018-12-31	Liabilities / assets	37.4%	Total Liabilities: 5344350 Open source Total Assets: 14280617 Open source
20232023-12-31	Liabilities / assets	55.4%	Total Liabilities: 7602216 Open source Total Assets: 13711870 Open source
20242024-12-31	Liabilities / assets	29.4%	Total Liabilities: 10724708 Open source Total Assets: 36484484 Open source
20252025-12-31	Liabilities / assets	33.5%	Total Liabilities: 8126764 Open source Total Assets: 24253300 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.99× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	2.76×	Current Assets: 9449114 Open source Current Liabilities: 3420935 Open source
20162016-12-31	Current assets / current liabilities	0.57×	Current Assets: 4154038 Open source Current Liabilities: 7308058 Open source
20172017-12-31	Current assets / current liabilities	0.57×	Current Assets: 8459305 Open source Current Liabilities: 14833536 Open source
20182018-12-31	Current assets / current liabilities	2.19×	Current Assets: 8478433 Open source Current Liabilities: 3864382 Open source
20232023-12-31	Current assets / current liabilities	2.9×	Current Assets: 4738031 Open source Current Liabilities: 1633995 Open source
20242024-12-31	Current assets / current liabilities	4.94×	Current Assets: 29706012 Open source Current Liabilities: 6008713 Open source
20252025-12-31	Current assets / current liabilities	5.99×	Current Assets: 21748448 Open source Current Liabilities: 3631498 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	Unavailable Not reported for this period.	−USD 4.46 million Exact value Exact value: -4459169 USD 2015-01-01 – 2015-12-31: -4459169 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2015-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -4459169 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4459169 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420417010635/eyeg-20161231.xml#102179 Filing: 000114420417010635 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	Unavailable Not reported for this period.	−USD 8.41 million Exact value Exact value: -8413180 USD 2016-01-01 – 2016-12-31: -8413180 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2016-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -8413180 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8413180 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/eyeg-20171231.xml#93442 Filing: 000114420418012542 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2016-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/eyeg-20171231.xml#348620 Filing: 000114420418012542 The citation records this snapshot. The page link may show a newer release later.	−USD 8.41 million Calculation and evidence -8413180 − 0 USD Exact free cash flow: -8413180 USD 2016-01-01 – 2016-12-31: -8413180 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2016-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -8413180 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8413180 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/eyeg-20171231.xml#93442 Filing: 000114420418012542 Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/eyeg-20171231.xml#348620 Filing: 000114420418012542 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 13.22 million Exact value Exact value: -13217917 USD 2017-01-01 – 2017-12-31: -13217917 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2017-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: -13217917 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13217917 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#94165 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.	−USD 6.47 million Exact value Exact value: -6468541 USD 2017-01-01 – 2017-12-31: -6468541 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2017-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -6468541 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6468541 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98371 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.	USD 36,999 Exact value Exact value: 36999 USD 2017-01-01 – 2017-12-31: 36999 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2017-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 36999 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36999 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98774 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.	−USD 6.51 million Calculation and evidence -6468541 − 36999 USD Exact free cash flow: -6505540 USD 2017-01-01 – 2017-12-31: -6468541 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 36999 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2017-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -6505540 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6468541 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98371 Filing: 000114420419011634 Input fundies:CapitalExpenditure: 36999 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98774 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 10.81 million Exact value Exact value: -10811423 USD 2018-01-01 – 2018-12-31: -10811423 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2018-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: -10811423 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10811423 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#94019 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.	−USD 10.84 million Exact value Exact value: -10844512 USD 2018-01-01 – 2018-12-31: -10844512 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2018-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -10844512 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10844512 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98167 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.	USD 20,000 Exact value Exact value: 20000 USD 2018-01-01 – 2018-12-31: 20000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2018-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 20000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98574 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.	−USD 10.86 million Calculation and evidence -10844512 − 20000 USD Exact free cash flow: -10864512 USD 2018-01-01 – 2018-12-31: -10844512 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 20000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2018-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -10864512 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10844512 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98167 Filing: 000114420419011634 Input fundies:CapitalExpenditure: 20000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/eyeg-20181231.xml#98574 Filing: 000114420419011634 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 13.77 million Exact value Exact value: -13770685 USD 2021-01-01 – 2021-12-31: -13770685 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2021-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: -13770685 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13770685 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1101657 Filing: 000137251423000050 The citation records this snapshot. The page link may show a newer release later.	−USD 10.68 million Exact value Exact value: -10675390 USD 2021-01-01 – 2021-12-31: -10675390 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2021-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -10675390 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10675390 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1127075 Filing: 000137251423000050 The citation records this snapshot. The page link may show a newer release later.	USD 63,865 Exact value Exact value: 63865 USD 2021-01-01 – 2021-12-31: 63865 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2021-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 63865 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63865 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1129738 Filing: 000137251423000050 The citation records this snapshot. The page link may show a newer release later.	−USD 10.74 million Calculation and evidence -10675390 − 63865 USD Exact free cash flow: -10739255 USD 2021-01-01 – 2021-12-31: -10675390 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 63865 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2021-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -10739255 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10675390 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1127075 Filing: 000137251423000050 Input fundies:CapitalExpenditure: 63865 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1129738 Filing: 000137251423000050 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 13.58 million Exact value Exact value: -13583610 USD 2022-01-01 – 2022-12-31: -13583610 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2022-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: -13583610 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13583610 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000026/kprx-20231231.htm#1094472 Filing: 000137251424000026 The citation records this snapshot. The page link may show a newer release later.	−USD 10.43 million Exact value Exact value: -10428133 USD 2022-01-01 – 2022-12-31: -10428133 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2022-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -10428133 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10428133 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000026/kprx-20231231.htm#1118132 Filing: 000137251424000026 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2022-01-01 – 2022-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2022-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1129096 Filing: 000137251423000050 The citation records this snapshot. The page link may show a newer release later.	−USD 10.43 million Calculation and evidence -10428133 − 0 USD Exact free cash flow: -10428133 USD 2022-01-01 – 2022-12-31: -10428133 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2022-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -10428133 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10428133 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000026/kprx-20231231.htm#1118132 Filing: 000137251424000026 Input fundies:CapitalExpenditure: 0 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000050/kprx-20221231.htm#1129096 Filing: 000137251423000050 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 12.51 million Exact value Exact value: -12513896 USD 2023-01-01 – 2023-12-31: -12513896 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2023-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: -12513896 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12513896 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000012/kprx-20241231.htm#1722492 Filing: 000137251425000012 The citation records this snapshot. The page link may show a newer release later.	−USD 9.56 million Exact value Exact value: -9556951 USD 2023-01-01 – 2023-12-31: -9556951 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2023-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -9556951 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9556951 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000012/kprx-20241231.htm#1123890 Filing: 000137251425000012 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2023-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000012/kprx-20241231.htm#1126318 Filing: 000137251425000012 The citation records this snapshot. The page link may show a newer release later.	−USD 9.56 million Calculation and evidence -9556951 − 0 USD Exact free cash flow: -9556951 USD 2023-01-01 – 2023-12-31: -9556951 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2023-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -9556951 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9556951 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000012/kprx-20241231.htm#1123890 Filing: 000137251425000012 Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000012/kprx-20241231.htm#1126318 Filing: 000137251425000012 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 3.59 million Exact value Exact value: 3594733 USD 2024-01-01 – 2024-12-31: 3594733 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2024-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: 3594733 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3594733 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1095446 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.	USD 8.56 million Exact value Exact value: 8559115 USD 2024-01-01 – 2024-12-31: 8559115 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2024-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: 8559115 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8559115 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1127585 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.	USD 6,256 Exact value Exact value: 6256 USD 2024-01-01 – 2024-12-31: 6256 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2024-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 6256 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6256 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1130000 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.	USD 8.55 million Calculation and evidence 8559115 − 6256 USD Exact free cash flow: 8552859 USD 2024-01-01 – 2024-12-31: 8559115 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 6256 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2024-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: 8552859 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8559115 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1127585 Filing: 000137251426000024 Input fundies:CapitalExpenditure: 6256 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1130000 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 10.84 million Exact value Exact value: -10835154 USD 2025-01-01 – 2025-12-31: -10835154 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Net Income: -10835154 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10835154 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1094683 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.	−USD 9.96 million Exact value Exact value: -9961176 USD 2025-01-01 – 2025-12-31: -9961176 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Operating Cash Flow: -9961176 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9961176 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1126938 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.	USD 110,789 Exact value Exact value: 110789 USD 2025-01-01 – 2025-12-31: 110789 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Capital Expenditure: 110789 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 110789 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1129415 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.	−USD 10.07 million Calculation and evidence -9961176 − 110789 USD Exact free cash flow: -10071965 USD 2025-01-01 – 2025-12-31: -9961176 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 110789 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIORA PHARMACEUTICALS, INC. · 2025-12-31 KIORA PHARMACEUTICALS, INC. (edgar:1372514) Free cash flow: -10071965 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372514?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9961176 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1126938 Filing: 000137251426000024 Input fundies:CapitalExpenditure: 110789 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm#1129415 Filing: 000137251426000024 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

175 filings · 3,953 latest values · 3,953 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001372514, 1372514, EYEG, KPHMW, KPRX, edgar:1372514

Also known as EYEGATE PHARMACEUTICALS INC, EYEGATE PHARMACEUTICALS, INC., KIORA PHARMACEUTICALS INC, KIORA PHARMACEUTICALS, INC, KIORA PHARMACEUTICALS, INC., KIORA PHARMACEUTICALS, INC, KIORA PHARMACEUTICALS, INC.

KIORA PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation